Shree Pacetronix Ltd vs Suraksha Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Shree Pacetronix Ltd is ₹ 158.1 as of 23 Oct 15:30 . The P/E Ratio of Shree Pacetronix Ltd changed from 77.1 on March 2021 to 10.9 on March 2026 . This represents a CAGR of -27.82% over 6 yearsThe P/E Ratio of Suraksha Diagnostic Ltd changed from 42.2 on March 2025 to 36.9 on March 2026 . This represents a CAGR of -6.49% over 2 years The Market Cap of Shree Pacetronix Ltd changed from ₹ 4.16 crore on March 2021 to ₹ 34.33 crore on March 2026 . This represents a CAGR of 42.16% over 6 yearsThe Market Cap of Suraksha Diagnostic Ltd changed from ₹ 1342 crore on March 2025 to ₹ 1187 crore on March 2026 . This represents a CAGR of -5.95% over 2 years The revenue of Shree Pacetronix Ltd for the Jun '26 is ₹ 4.92 crore as compare to the Mar '26 revenue of ₹ 5.41 crore. This represent the decline of -9.06% The revenue of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 88.73 crore as compare to the Mar '26 revenue of ₹ 82.2 crore. This represent the growth of 7.94% The ebitda of Shree Pacetronix Ltd for the Jun '26 is ₹ 1.21 crore as compare to the Mar '26 ebitda of ₹ 1.68 crore. This represent the decline of -27.98% The ebitda of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 31.53 crore as compare to the Mar '26 ebitda of ₹ 25.15 crore. This represent the growth of 25.37% The net profit of Shree Pacetronix Ltd changed from ₹ 0.37 crore to ₹ 0.76 crore over 9 quarters. This represents a CAGR of 37.70% The net profit of Suraksha Diagnostic Ltd changed from ₹ 7.67 crore to ₹ 12.85 crore over 9 quarters. This represents a CAGR of 25.78% The Dividend Payout of Shree Pacetronix Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suraksha Diagnostic Ltd changed from 0.76 % on March 2026 to 0.76 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Shree Pacetronix Ltd

Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993.
It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum. Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias.
These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions.
Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda.
These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry.

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata.
Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India.
In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors.

FAQs for the comparison of Shree Pacetronix Ltd and Suraksha Diagnostic Ltd

Which company has a larger market capitalization, Shree Pacetronix Ltd or Suraksha Diagnostic Ltd?

Market cap of Shree Pacetronix Ltd is 59 Cr while Market cap of Suraksha Diagnostic Ltd is 1,556 Cr

What are the key factors driving the stock performance of Shree Pacetronix Ltd and Suraksha Diagnostic Ltd?

The stock performance of Shree Pacetronix Ltd and Suraksha Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shree Pacetronix Ltd and Suraksha Diagnostic Ltd?

As of October 25, 2026, the Shree Pacetronix Ltd stock price is INR ₹158.1. On the other hand, Suraksha Diagnostic Ltd stock price is INR ₹298.9.

How do dividend payouts of Shree Pacetronix Ltd and Suraksha Diagnostic Ltd compare?

To compare the dividend payouts of Shree Pacetronix Ltd and Suraksha Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.